Key clinical point: First‐generation cephalosporins are still the appropriate empiric therapy for most pediatric atopic dermatitis patients.
Major finding: Methicillin‐sensitive S. aureus (77.8%) was more prevalent than methicillin‐resistant S. aureus (22.2%) in pediatric AD patients.
Study details: A retrospective cohort study of skin cultures from 106 pediatric atopic dermatitis patients with clinically apparent bacterial skin infections.
Disclosures: The study was funded by grants from the Agency for Healthcare Research and Quality. The authors reported no conflicts of interest.
Briscoe CC et al. Pediatr Dermatol. 2019 May 24. doi: 10.1111/pde.13867.